Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Safety, Efficacy of Semaglutide for Inadequately Controlled T2D

Safety, Efficacy of Semaglutide for Inadequately Controlled T2D

By

Patients with type 2 diabetes who received once-weekly semaglutide had statistically greater reductions in HbA1c and body weight compared with those treated with dulaglutide.

Two New Diabetes Medications Now Available

Two New Diabetes Medications Now Available

By

Two recently-approved diabetes treatments, a semaglutide injection and an insuline aspart injection, are now available in pharmacies across the United States.

FDA Approves Somatropin Injection to Treat Growth Hormone Deficiency

FDA Approves Somatropin Injection to Treat Growth Hormone Deficiency

By

The FDA has approved Zomacton, a somatropin injection, for the replacement of growth hormone in adults with GH deficiency.

Update on Discontinuation of Tanzeum Injections

Update on Discontinuation of Tanzeum Injections

By

The initial decision to discontinue Tanzeum was announced in August 2017 due to limited prescribing of the drug and not because of safety concerns.

NovoFine 30G 8mm Pen Needle Will Be Discontinued

NovoFine 30G 8mm Pen Needle Will Be Discontinued

By

Novo Nordisk has announced that the NovoFine 30G 8mm pen needle will be discontinued on or before April 30, 2018.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-Newsletters

CME Focus